Help us: Donate
Follow us on:
×

Menu

Back

SIWA Therapeutics

Organization Description

SIWA Therapeutics are developing an immunotherapy approach to senescent cell accumulation and cancer. Their approach is really a typical monoclonal antibody product, the same sort of immunotherapy that’s used in a variety of cancer therapies. SIWA claims to have found a marker that’s on cancer cells and senescent cells because of the way the markers are produced, and therefore the monoclonal antibody can enable removal of those senescent or cancer cells.

Team

Lewis Gruber

SIWA Therapeutics

Related Topics